
AnaptysBio, Inc.
USD53.76
+3.47 (+6.90%)
CEO
Daniel Faga
IPO Date
2017-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$49.89
Prev. Close
$50.29
Day Low
$49.71
Day High
$53.77
52W Low
$11.40
52W High
$72.36
Market Cap
$2.32B
Volume
1.24M
| 28 Apr 2026 |
| Leerink Partners |
| Outperform |
| Outperform |
| maintain |
| 22 Apr 2026 | Barclays | Overweight | Overweight | maintain |
| 21 Apr 2026 | UBS | Buy | Buy | maintain |
| 31 Mar 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 30 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 17 Mar 2026 | UBS | Buy | Buy | maintain |
| 12 Mar 2026 | Wedbush | Outperform | Outperform | maintain |